dementia glp-1 Could diabetes and weight loss drugs treat Alzheimer's disease? Can GLP-1 Weight Loss Drugs

Novo Nordisk has announced the results of a trial of CagriSema for the treatment of stage 2 diabetes, which proved that CagriSema's hypoglycemic effect is better than that of semeglutide, and nearly 90% of subjects have achieved the HbA1c goal

A survey of people with a mast cell activation syndrome diagnosis found that 94% had abdominal pain, and 89% had skin-related issues (dermatographism and flushing)

Niacinamide: Niacinamide, or vitamin B3, is a powerful antioxidant that improves the skin's barrier function, evens out skin tone and reduces the appearance of pores

2 and Additional file 1: Fig

Hepatocyte nuclei may be smaller than normal

The formulation preferentially accumulated in I/R lesions, bypassing hepatic metabolism, and enhanced anti-inflammatory and anti-apoptotic responses while improving cardiac function [162].The development of intelligent nanocarriers has garnered significant attention